Document: Medicine Shortage Communication (MSC): Endoxan / Sendoxan / Genoxal (cyclophosphamide), 100 mg, 200 mg, 500 mg, 1 g and 2 g, powder for solution for injection or infusion New-2026/3/24

Document: Cardiac valves - Notified Body 0344 - 07/12/2021 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)-2026/3/24

Document: Medicinal products for human use: monthly figures - February 2026-2026/3/24

Page: Guidance on good manufacturing practice and good distribution practice: Questions and answers-2026/3/24

Document: Questions and answers on the implementation of 3DP technology (Additive Manufacturing Technology) for solid oral dosage forms-2026/3/24

Document: Records of data processing activity for the handling of data subjects’ requests-2026/3/24

Document: European Medicines Agency's data protection notice for the handling of data subjects’ requests-2026/3/24

Page: Website outages and upgrades-2026/3/24

Document: Medicine Shortage Communication (MSC): Insulin (human insulin) (various short-, rapid-, intermediate-, mixed- and long-acting forms) 2026-2026/3/23

Page: Good Manufacturing Practice (GMP) / Good Distribution Practice (GDP) Inspectors Working Group-2026/3/23